• PRESS RELEASE

    PRESS RELEASE

    Learn More

  • Our Pipeline

    OUR PIPELINE

    A series of first-in-class antibody drugs and biosimilars are currently under advanced clinical and nonclinical development stages. Based on scientific capabilities and innovative technologies, we are developing novel antibody therapeutics and biosimilar drugs.

    Learn More

  • Our Technology

    R&D

    Prestige Biopharma facilitates pharmaceutical R&D activities through well-equipped multidisciplinary infrastructure ranging from discovery through preclinical and clinical development.

    Learn More